Americas Gastrointestinal Drugs Market

ID: MRFR/Pharma/0140-HCR 50 Pages Rahul Gotadki Last Updated: October 05, 2026
Americas Gastrointestinal Drugs Market Research Report, by Drug Category (Acid Neutralizers, Laxatives and Antidiarrheal, Anti-inflammatory drugs, and Others), By Route of Administration (Oral, Parenteral, Rectal), By disease type (Gastroesophageal Reflux Disease, Inflammatory Bowel Disease and Other), By end user (Hospital Pharmacies, Retail Pharmacies and Other) - Forecast till 2035
Americas Gastrointestinal Drugs Market
Market Size
Forecast Period2025-2035
CAGR (2025-2035)4.34%
2023 Market Size$ 11.2 Billion
2024 Market Size$ 12.3 Billion
2035 Market Size$ 19.7 Billion
Key Players
AbbVie Inc.
AstraZeneca
Valeant
Abbott Laboratories
Allergan Plc
Bayer AG
Opportunities
  • No data available
  1. 1 INTRODUCTION
    1. 1.1 DEFINITION
    2. 1.2 SCOPE OF STUDY
      1. 1.2.1 RESEARCH OBJECTIVE
      2. 1.2.2 ASSUMPTIONS & LIMITATIONS
        1. 1.2.2.1 ASSUMPTIONS
        2. 1.2.2.2 LIMITATIONS
    3. 1.3 MARKET STRUCTURE:
  2. 2 RESEARCH METHODOLOGY
    1. 2.1 RESEARCH PROCESS:
    2. 2.2 PRIMARY RESEARCH
    3. 2.3 SECONDARY RESEARCH:
  3. 3 MARKET DYNAMICS
    1. 3.1 DRIVERS
    2. 3.2 RESTRAINTS
    3. 3.3 OPPORTUNITIES
    4. 3.4 MACROECONOMIC INDICATORS
  4. 4 MARKET FACTOR ANALYSIS
    1. 4.1 PORTERS FIVE FORCES MODEL
    2. 4.2 BARGAINING POWER OF SUPPLIERS
    3. 4.3 BARGAINING POWER OF BUYERS
    4. 4.4 THREAT OF NEW ENTRANTS
    5. 4.5 THREAT OF SUBSTITUTES
    6. 4.6 INTENSITY OF RIVALRY
  5. 5 Americas Gastrointestinal Drugs Market, BY DRUG CATEGORY
    1. 5.1 ACID NEUTRALIZERS
      1. 5.1.1 ANTACID
      2. 5.1.2 H2 ANATAGONISTS
      3. 5.1.3 PROTON PUMP INHIBITORS
      4. 5.1.4 OTHERS
    2. 5.2 LAXATIVES & ANTIDIARRHEAL
    3. 5.3 ANTINFLAMMATORY
    4. 5.4 ANTIEMETIC
    5. 5.5 OTHER
  6. 6 Americas Gastrointestinal Drugs Market, BY ROUTE OF ADMINISTRATION
    1. 6.1 ORAL
    2. 6.2 PARENTAL
    3. 6.3 RECTAL
  7. 7 AMERICAS GASTROINTESTINAL Americas Gastrointestinal Drugs Market, BY DISEASES TYPE
    1. 7.1 GASTROESPHAGEAL REFLUX DISEASES
    2. 7.2 INFLAMMATORY BOWEL DISEASES
      1. 7.2.1 CHRON’S DISEASE
      2. 7.2.2 ULCERTAVIE COLITIS
        1. 7.2.2.1 ULCERATIVE PROCTITIS
        2. 7.2.2.2 PROCTOSIGMOIDITIS
        3. 7.2.2.3 LEFT SIDED COLITIS
        4. 7.2.2.4 PANCOLITIS
        5. 7.2.2.5 ACUTE SEVERE ULCERTATIVE COLITIS
    3. 7.3 OTHER.
  8. 8 Americas Gastrointestinal Drugs Market, BY END USERS
    1. 8.1 HOSPITAL PHARMACIES
    2. 8.2 RETAIL PHARMACIES
    3. 8.3 OTHERS
  9. 9 AMERICAS Americas Gastrointestinal Drugs Market, BY REGION
    1. 9.1 INTRODUCTION
      1. 9.1.2 NORTH AMERICA
    2. 91.3 SOUTH AMERICA
  10. 10 COMPETITIVE LANDSCAPE
    1. 10.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
      1. 10.1.1 STRATEGIC PARTNERSHIP
      2. 10.1.2 MERGER & ACQUISITION
  11. 11 COMPANY PROFILE
    1. 11.1 ABBVIE INC.
      1. 11.1.1 OVERVIEW
      2. 11.1.2 PRODUCT OVERVIEW
      3. 11.1.3 FINANCIALS
      4. 11.1.4 KEY DEVELOPMENTS
    2. 11.2 ABBOTT LABORATORIES
      1. 11.2.1 OVERVIEW
      2. 11.2.2 PRODUCT OVERVIEW
      3. 11.2.3 FINANCIALS
      4. 11.2.4 KEY DEVELOPMENTS
    3. 11.3 ALLERGEN PLC.
      1. 11.3.1 OVERVIEW
      2. 11.3.2 PRODUCT OVERVIEW
      3. 11.3.3 FINANCIALS
      4. 11.3.4 STRATEGY
      5. 11.3.5 KEY DEVELOPMENT
    4. 11.4 BAYER AG
      1. 11.4.1 OVERVIEW
      2. 11.4.2 PRODUCT OVERVIEW
      3. 11.4.3 FINANCIALS
      4. 11.4.4 KEY DEVELOPMENTS
    5. 11.5 BOEHRINGER INGELHEIM GMBH
      1. 11.5.1 OVERVIEW
      2. 11.5.2 PRODUCT OVERVIEW
      3. 11.5.3 FINANCIALS
      4. 11.5.4 KEY DEVELOPMENTS
    6. 11.6 GALXOSMITHKLINE
      1. 11.6.1 OVERVIEW
      2. 11.6.2 PRODUCT OVERVIEW
      3. 11.6.3 FINANCIALS
      4. 11.6.4 KEY DEVELOPMENTS
    7. 11.7 JASSEN PHARMACEUTICALS INC
      1. 11.7.1 OVERVIEW
      2. 11.7.2 PRODUCT OVERVIEW
      3. 11.7.3 FINANCIALS
      4. 11.7.4 KEY DEVELOPMENTS
  12. 11 8 OTHERS

Americas Gastrointestinal Drugs Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.